1. 1. Baser O, Xie L, Pesa J, Durkin M. Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics. Journal of medical economics. 2015;18(5):357-65. 2. Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, et al. Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophrenia bulletin. 2018;44(6):1195-203. 3. Mueser KT, Jeste DV. Clinical handbook of schizophrenia: Guilford Press; 2011. 4. Tsapakis EM, Dimopoulou T, Tarazi FI. Clinical management of negative symptoms of schizophrenia: An update. Pharmacol Ther. 2015;153:135-47. 5. Keskinen E, Marttila A, Marttila R, Jones P, Murray G, Moilanen K, et al. Interaction between parental psychosis and early motor development and the risk of schizophrenia in a general population birth cohort. European Psychiatry. 2015;30(6):719-27. 6. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67-76. 7. Ritsner MS. Handbook of schizophrenia spectrum disorders, volume III: Therapeutic approaches, comorbidity, and outcomes: Springer; 2011. 8. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Archives of general psychiatry. 2007;64(10):1123-31. 9. Lambert TJ, Newcomer JW. Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Medical Journal of Australia. 2009;190(S4):S39-S42. 10. Mueser KT, McGurk SR. Schizophrenia. The Lancet. 2004;363(9426):2063-72. 11. Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, et al. Definition and description of schizophrenia in the DSM-5. Schizophrenia research. 2013;150(1):3-10. 12. Fink G, Sumner BE, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cellular and molecular neurobiology. 1996;16(3):325-44. 13. Sayed Y, Taxel P. The use of estrogen therapy in men. Current opinion in pharmacology. 2003;3(6):650-4. 14. Seeman MV. The role of estrogen in schizophrenia. Journal of Psychiatry and Neuroscience. 1996;21(2):123. 15. Leung M.D. DA, Chue M. R. C. Psych. DP. Sex differences in schizophrenia, a review of the literature. Acta Psychiatrica Scandinavica. 2000;101(401):3-38. 16. Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender Differences in Schizophrenia and First-Episode Psychosis: A Comprehensive Literature Review. Schizophrenia Research and Treatment. 2012;2012:916198. 17. Markham JA. Sex steroids and schizophrenia. Reviews in Endocrine and Metabolic Disorders. 2012;13(3):187-207. 18. Aleman A, Kahn RS, Selten J-P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Archives of general psychiatry. 2003;60(6):565-71. 19. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC medicine. 2004;2(1):1-22. 20. Seeman MV. Interaction of sex, age, and neuroleptic dose. Comprehensive Psychiatry. 1983;24(2):125-8. 21. Dalton K. Menstruation and acute psychiatric illnesses. British medical journal. 1959;1(5115):148. 22. Chang S, Renshaw D. Psychosis and pregnancy. Comprehensive Therapy. 1986;12(10):36-41. 23. Kendell R, Chalmers J, Platz C. Epidemiology of puerperal psychoses. The British Journal of Psychiatry. 1987;150(5):662-73. 24. Bergemann N, Mundt C, Parzer P, Jannakos I, Nagl I, Salbach B, et al. Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophrenia research. 2005;73(2-3):357-66. 25. Riecher-Rössler A, Häfner H, Stumbaum M, Maurer K, Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophrenia bulletin. 1994;20(1):203-14. 26. Häfner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Löffler W, et al. Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophrenia Bulletin. 1998;24(1):99-113. 27. Chavez C, Hollaus M, Scarr E, Pavey G, Gogos A, van den Buuse M. The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study. Brain research. 2010;1321:51-9. 28. Sánchez MG, Bourque M, Morissette M, Di Paolo T. Steroids‐dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS neuroscience & therapeutics. 2010;16(3):e43-e71. 29. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? The American journal of psychiatry. 1996. 30. Sass LA, Parnas J. Schizophrenia, consciousness, and the self. Schizophrenia bulletin. 2003;29(3):427-44. 31. DeLisi LE, Szulc KU, Bertisch HC, Majcher M, Brown K. Understanding structural brain changes in schizophrenia. Dialogues in clinical neuroscience. 2022. 32. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocrine reviews. 1999;20(3):279-307. 33. Arimatsu Y, Hatanaka H. Estrogen treatment enhances survival of cultured fetal rat amygdala neurons in a defined medium. Developmental Brain Research. 1986;26(1):151-9. 34. Goodman Y, Bruce AJ, Cheng B, Mattson MP. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β‐peptide toxicity in hippocampal neurons. Journal of neurochemistry. 1996;66(5):1836-44. 35. Behl C, Skutella T, Frank LH, Post A, Widmann M, Newton CJ, et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Molecular pharmacology. 1997;51(4):535-41. 36. Sarvari M, Kallo I, Hrabovszky E, Solymosi N, Toth K, Liko I, et al. Estradiol replacement alters expression of genes related to neurotransmission and immune surveillance in the frontal cortex of middle-aged, ovariectomized rats. Endocrinology. 2010;151(8):3847-62. 37. Garcia-Segura LM, Cardona-Gomez P, Naftolin F, Chowen JA. Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport. 1998;9(4):593-7. 38. Perlman WR, Tomaskovic-Crook E, Montague DM, Webster MJ, Rubinow DR, Kleinman JE, et al. Alteration in estrogen receptor α mRNA levels in frontal cortex and hippocampus of patients with major mental illness. Biological psychiatry. 2005;58(10):812-24.